Chicago Capital Management
CHICAGO, ILfiles as Chicago Capital Management, LLC
$52m in 14 US stocks at the end of 30 June 2026. The top 10 are 98.1% of the money. It changed about 79.1% of the portfolio this quarter.
Value
$52m
Stocks
14
Top 10 share
98.1%
Turnover
79.1%
What changed this quarter
New
Bought for the first time this quarter.
- Nuvalent21.1% of the fund
- Apogee TherapeuticsAPGE18.8% of the fund
- Taylor Morrison Home13.7% of the fund
- Catalyst Pharmaceuticals5.6% of the fund
- AstroNovaALOT5.5% of the fund
- Esperion Therapeutics INC NE5.0% of the fund
- Bio-TechneTECH3.9% of the fund
- Trubridge1.3% of the fund
- Stellar Bancorp0.7% of the fund
- NSTS BancorpNSTS0.6% of the fund
- Xerox HoldingsXRXDW<0.1% of the fund
Added
Bought more of a stock they already held.
None this quarter.
Cut
Sold some of their stake.
None this quarter.
Sold out
Sold their entire stake.
- Janus Henderson Group-100%
- Arcellx-100%
- Amicus Therapeutics-100%
- Apellis Pharmaceuticals-100%
- Terns Pharmaceuticals-100%
- Diamond Hill Invt Group INC COM New-100%
- Blue Foundry BancorpBLFY-100%
- Thermon Group Hldgs-100%
- DAY One Biopharmaceuticals I-100%
- Heritage Comm-100%
Holdings
- Nuvalent
- Share
- 21.1%
- Value
- $11m
- Shares
- 115,500
New
- Apogee TherapeuticsAPGE
- Share
- 18.8%
- Value
- $10m
- Shares
- 97,100
New
- Chart Inds
- Share
- 16.0%
- Value
- $8m
- Shares
- 53,000
Held
- Taylor Morrison Home
- Share
- 13.7%
- Value
- $7m
- Shares
- 133,000
New
- Hewlett Packard Enterprise C
- Share
- 7.3%
- Value
- $4m
- Shares
- 32,900
Held
- Catalyst Pharmaceuticals
- Share
- 5.6%
- Value
- $3m
- Shares
- 122,650
New
- AstroNovaALOT
- Share
- 5.5%
- Value
- $3m
- Shares
- 131,100
New
- Esperion Therapeutics INC NE
- Share
- 5.0%
- Value
- $3m
- Shares
- 830,935
New
- Trubridge
- Share
- 1.3%
- Value
- $685,785
- Shares
- 34,663
New
- Stellar Bancorp
- Share
- 0.7%
- Value
- $342,427
- Shares
- 11,559
New
- Electronic ArtsEA
- Share
- 0.6%
- Value
- $309,200
- Shares
- 2,000
Held
- Xerox HoldingsXRXDW
- Share
- <0.1%
- Value
- $26,395
- Shares
- 95,980
New
| Company | Share of fund | Value | Shares | Change |
|---|---|---|---|---|
| Nuvalent | 21.1% | $11m | 115,500 | New |
| Apogee TherapeuticsAPGE | 18.8% | $10m | 97,100 | New |
| Chart Inds | 16.0% | $8m | 53,000 | Held |
| Taylor Morrison Home | 13.7% | $7m | 133,000 | New |
| Hewlett Packard Enterprise C | 7.3% | $4m | 32,900 | Held |
| Catalyst Pharmaceuticals | 5.6% | $3m | 122,650 | New |
| AstroNovaALOT | 5.5% | $3m | 131,100 | New |
| Esperion Therapeutics INC NE | 5.0% | $3m | 830,935 | New |
| Bio-TechneTECH | 3.9% | $2m | 37,509 | New |
| Trubridge | 1.3% | $685,785 | 34,663 | New |
| Stellar Bancorp | 0.7% | $342,427 | 11,559 | New |
| Electronic ArtsEA | 0.6% | $309,200 | 2,000 | Held |
| NSTS BancorpNSTS | 0.6% | $303,793 | 29,020 | New |
| Xerox HoldingsXRXDW | <0.1% | $26,395 | 95,980 | New |
Over time and by industry
Value over time
Jun '25
Dec '25
Jun '26
Value is up 25.4% since 30 June 2025.
Where the money is
Health care22.6%
Technology6.0%
Financial services0.6%
Other70.8%
From the fund's 13F filings. They list US stocks and options only, 45 days after each quarter, and leave out cash, bonds, shorts and foreign shares.